US$ 26.91
dual gip and glp-1 receptor agonist GLP-1/GIP | Tirzepatide | Obesity & T2DM Mx | Harrison's Update(22nd Ed.) The mechanisms of dual incretin
Description
Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis

Pappas, T

Diabetes Obes Metab (2016) 18:22435

Yao, Y., Xu, X
The carbohydrate-insulin model of obesity
